The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Injection allergen immunotherapy for asthma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2010
|
| DOI | 10.1002/14651858.cd001186.pub2 |
| Pubmed ID | |
| Authors |
Michael J Abramson, Robert M Puy, John M Weiner |
| Abstract |
Allergen specific immunotherapy has long been a controversial treatment for asthma. Although beneficial effects upon clinically relevant outcomes have been demonstrated in randomised controlled trials, there remains a risk of severe and sometimes fatal anaphylaxis. The recommendations of professional bodies have ranged from cautious acceptance to outright dismissal. With increasing interest in new allergen preparations and methods of delivery, we updated the systematic review of allergen specific immunotherapy for asthma. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 6 | 27% |
| United States | 3 | 14% |
| Canada | 2 | 9% |
| Argentina | 1 | 5% |
| France | 1 | 5% |
| Chile | 1 | 5% |
| Spain | 1 | 5% |
| Israel | 1 | 5% |
| Australia | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 5 | 23% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 59% |
| Scientists | 5 | 23% |
| Practitioners (doctors, other healthcare professionals) | 3 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 325 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Korea, Republic of | 2 | <1% |
| Germany | 2 | <1% |
| Portugal | 1 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 318 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 38 | 12% |
| Researcher | 38 | 12% |
| Student > Master | 33 | 10% |
| Student > Bachelor | 25 | 8% |
| Student > Ph. D. Student | 21 | 6% |
| Other | 62 | 19% |
| Unknown | 108 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 125 | 38% |
| Agricultural and Biological Sciences | 17 | 5% |
| Immunology and Microbiology | 14 | 4% |
| Biochemistry, Genetics and Molecular Biology | 12 | 4% |
| Nursing and Health Professions | 11 | 3% |
| Other | 29 | 9% |
| Unknown | 117 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 75. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2024.
All research outputs
#615,340
of 26,483,923 outputs
Outputs from Cochrane database of systematic reviews
#1,022
of 13,256 outputs
Outputs of similar age
#1,519
of 106,889 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 75 outputs
Altmetric has tracked 26,483,923 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,256 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,889 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.